Web Analytics

Start up Profile

Curevo Vaccine

Curevo Vaccine United States - Bothell, Washington
START UP

1 Disclosed Funding Rounds $110,000,000
0 Participating Investments




Curevo Vaccine is a clinical-stage developer of vaccines for varicella and herpes zoster. Amezosvatein (CRV-101) is an adjuvanted subunit (non-mRNA) vaccine designed to prevent herpes zoster,

Capital Raised

Date Round Raised Participating Investors
March, 19 ,2025 Series B $110,000,000